Signaling pathways
-
BA8248 LFHP-1cSummary: LFHP-1c is an inhibitor with neuroprotective activity in ischemic stroke. - BA8249 CAY10650Summary: CAY10650 is a potent inhibitor of cytoplasmic phospholipase A2α.
- BA8250 LEI-401Summary: LEI-401 is a first-of-its-kind, selective, blood-brain barrier-crossing inhibitor of (N-acylphosphoethanolamine phospholipase D).
- BA8251 CCT129957Summary: CCT129957 is an indole derivative.
- BA8253 RilapladibSummary: Rilapladib (SB659032) is a selective inhibitor of lipoprotein-associated phospholipase A.
- BA8254 GSK2647544Summary: GSK2647544 is an oral, selective inhibitor.
- BA8255 ASM-IN-1Summary: ASM-IN-1 is a potent orally active acid sphingomyelinase inhibitor.
- BA8256 ML-298Summary: ML298 is a potent and selective inhibitor.
- BA8257 LCL521Summary: LCL521 is an acidic ceramidase inhibitor.
- BA8258 Lp-PLA2-IN-3Summary: Lp-PLA2-IN-3 is a potent, orally available inhibitor of lipoprotein-associated phospholipase A2.